Search
Search
Dynabeads magnetic beads support applications across diagnostics, therapeutics, preventive healthcare, and medical devices. Through Dynabeads Technology—OEM, we help you develop and commercialize products with our proprietary magnetic bead technology.
For more than 35 years, we've partnered with biotech, pharmaceutical, diagnostic, and healthcare companies to develop verified magnetic bead solutions. Our OEM supply agreements help ensure consistent product performance and a reliable supply.
Our experienced professionals support every stage of development, from bead selection and workflow optimization to scale-up and commercial manufacturing. With access to the full Dynabeads portfolio and widely used manufacturing capabilities, you have the resources to move from development to commercialization with confidence.
Don’t see your application listed here?
Our two Norwegian manufacturing facilities operate to International Regulatory quality management standards, helping provide the reassurance of risk-managed, secure supply. For streamlined inventory management, each OEM customer is assigned a Dynabeads project manager who works alongside your operations team to help ensure adequate inventory is available when you need it.
As specialists in production scale-up, our flexible manufacturing capabilities enable seamless expansion of supply—from small prototype batches to bulk production—aligning with your business needs and allowing you to respond rapidly to market demand.
In addition to our extensive range of routinely available and standard Dynabeads, we also offer customized bead development, helping ensure you have the most appropriate beads for your needs, and helping to accelerate your time to market.
Our specialist scientists work alongside your R&D team to give advice on which bead product to use and how to optimize the conjugation of ligands and other parameters for optimal performance in your diagnostic assays.
Discuss your requirements with the technical team.
Enable high-quality liquid biopsy sample prep every time with Dynabeads MyOne CD45:
Seattle-based Key Proteo has a simple mission to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs. Key Proteo is doing this by developing novel proteomic-based newborn screening methods to radically change the course of treatable genetic diseases.
Through their research and development process, Key Proteo teamed up with Thermo Fisher Scientific’s Dynabeads OEM team to manufacture the magnetic beads utilized in their product. Their prior success in using Dynabeads magnetic beads prompted Key Proteo to request a feasibility study by Thermo Fisher in order to explore differences in Dynabeads architecture and chemistry. This study focused on identifying the number of distinct antibodies that could be coupled to the magnetic beads and exploring the different performances of Dynabeads products in the Key Proteo assay. Not only was it important for Key Proteo to identify the amount and number of antibodies that could successfully couple to the bead, but they also needed to understand the cost consequences of varying the number of antibodies, type of beads, conjugation strategy, and any affects to product stability through the entire workflow. These factors were balanced while maintaining the performance and cost effectiveness of Key Proteo’s newborn screening assay.
Thermo Fisher’s expertise in bulk antibody-Dynabeads reagent production as well as their overall expertise in magnetic bead technology has allowed Key Proteo to successfully continue to develop and manufacture their product. Their technology will allow the targeting of new or existing genetic conditions to change their clinical course and ensure a better quality of life for patients.
For Research Use Only. Not for use in diagnostic procedures.